Incentivizing diverse representation in clinical trials

At the Intersection of Science and Law

English - March 02, 2022 18:42 - 22 minutes - 20.8 MB
Life Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The crossroad of science and law

Next Episode: The moral imperative: Balancing innovation, regulation and prescription drug availability

Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.

See omnystudio.com/listener for privacy information.